RETREG1 and breast carcinoma: In previous study, we have already discovered that FAM134B can promote the progression of hepatocellular carcinoma, in order to explore whether FAM134B also plays a role in breast cancer, a comprehensive analysis of its correlation with survival rates among breast cancer patients was initially conducted using the Kaplan-Meier Plotter database.